BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 360$1,0330.00%
NORTHERN TRUST CORP 69,420$199,2350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 324,291$930,9810.00%
IFP Advisors, Inc 300$8610.00%
STATE STREET CORP 76,384$219,2220.00%
Cutler Group LLC / CA 700$20.00%
NewEdge Advisors, LLC 17$490.00%
Belvedere Trading LLC 980$2,8130.00%
CREDIT SUISSE AG/ 18,000$51,6600.00%
CITIGROUP INC 61,348$176,0690.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 14,484$41,5690.00%
Belvedere Trading LLC 10,000$28,7000.00%
MORGAN STANLEY 22,051$63,2860.00%
BlackRock Inc. 1,400,105$4,018,3020.00%
Citadel Advisors 17,600$50,5120.00%
Citadel Advisors 11,700$33,5790.00%
Citadel Advisors 18,771$53,8730.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 146,500$420,4550.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,200$75,1940.00%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q3 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.